Molina Healthcare, Inc (NYSE:MOH) Receives Consensus Recommendation of “Hold” from Brokerages

Molina Healthcare, Inc (NYSE:MOH) has been assigned an average recommendation of “Hold” from the seventeen research firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation, thirteen have issued a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $184.8125.

A number of equities research analysts recently weighed in on the stock. Royal Bank Of Canada assumed coverage on shares of Molina Healthcare in a report on Tuesday, June 23rd. They set a “sector perform” rating and a $216.00 price objective for the company. Mizuho set a $215.00 price objective on shares of Molina Healthcare in a report on Monday, June 8th. Cantor Fitzgerald lifted their price objective on shares of Molina Healthcare from $144.00 to $209.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Bank of America upgraded shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 price objective for the company in a report on Wednesday, April 29th. Finally, Robert W. Baird lifted their price objective on shares of Molina Healthcare from $124.00 to $163.00 and gave the company a “neutral” rating in a report on Monday, May 11th.

Insider Transactions at Molina Healthcare

In related news, CAO Maurice Hebert sold 600 shares of the company’s stock in a transaction dated Thursday, May 14th. The shares were sold at an average price of $191.55, for a total value of $114,930.00. Following the completion of the sale, the chief accounting officer directly owned 12,815 shares of the company’s stock, valued at $2,454,713.25. This represents a 4.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jeff D. Barlow sold 17,811 shares of the company’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the completion of the sale, the insider directly owned 67,175 shares of the company’s stock, valued at approximately $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 1.44% of the company’s stock.

Institutional Trading of Molina Healthcare

A number of hedge funds have recently added to or reduced their stakes in the business. Basecamp Wealth Advisors LLC lifted its stake in Molina Healthcare by 25.2% in the first quarter. Basecamp Wealth Advisors LLC now owns 716 shares of the company’s stock worth $95,000 after acquiring an additional 144 shares during the period. Pine Valley Investments Ltd Liability Co purchased a new stake in Molina Healthcare in the first quarter worth about $24,348,000. NewEdge Advisors LLC lifted its stake in Molina Healthcare by 9,176.9% in the first quarter. NewEdge Advisors LLC now owns 2,412 shares of the company’s stock worth $322,000 after acquiring an additional 2,386 shares during the period. Caerus Investment Advisors LLC purchased a new stake in Molina Healthcare in the first quarter worth about $259,000. Finally, Glenmede Trust Co. NA lifted its stake in Molina Healthcare by 37.7% in the first quarter. Glenmede Trust Co. NA now owns 2,114 shares of the company’s stock worth $282,000 after acquiring an additional 579 shares during the period. 98.50% of the stock is owned by hedge funds and other institutional investors.

Molina Healthcare Trading Up 0.0%

NYSE MOH opened at $229.81 on Monday. The stock has a market cap of $11.97 billion, a PE ratio of 67.99 and a beta of 0.80. Molina Healthcare has a 12 month low of $121.06 and a 12 month high of $311.52. The company’s 50-day moving average price is $186.48 and its 200-day moving average price is $168.43. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 0.97.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, April 22nd. The company reported $2.35 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The company had revenue of $10.80 billion during the quarter, compared to analyst estimates of $10.91 billion. During the same quarter last year, the business posted $6.08 EPS. The firm’s revenue for the quarter was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. Equities research analysts forecast that Molina Healthcare will post 5.23 earnings per share for the current year.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.